The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-Neoplastic Diseases in the Era of Precision Medicine

Molecular pathology diagnostics to subclassify diseases based on pathogenesis are increasingly common in clinical translational medicine. Molecular pathological epidemiology (MPE) is an integrative transdisciplinary science based on the unique disease principle and the disease continuum theory. Whil...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Epidemiology (Cambridge, Mass.) Mass.), 2016-07, Vol.27 (4), p.602-611
Hauptverfasser: Ogino, Shuji, Nishihara, Reiko, VanderWeele, Tyler J., Wang, Molin, Nishi, Akihiro, Lochhead, Paul, Qian, Zhi Rong, Zhang, Xuehong, Wu, Kana, Nan, Hongmei, Yoshida, Kazuki, Milner, Danny A, Chan, Andrew T., Field, Alison E., Camargo, Carlos A, Williams, Michelle A, Giovannucci, Edward L.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 611
container_issue 4
container_start_page 602
container_title Epidemiology (Cambridge, Mass.)
container_volume 27
creator Ogino, Shuji
Nishihara, Reiko
VanderWeele, Tyler J.
Wang, Molin
Nishi, Akihiro
Lochhead, Paul
Qian, Zhi Rong
Zhang, Xuehong
Wu, Kana
Nan, Hongmei
Yoshida, Kazuki
Milner, Danny A
Chan, Andrew T.
Field, Alison E.
Camargo, Carlos A
Williams, Michelle A
Giovannucci, Edward L.
description Molecular pathology diagnostics to subclassify diseases based on pathogenesis are increasingly common in clinical translational medicine. Molecular pathological epidemiology (MPE) is an integrative transdisciplinary science based on the unique disease principle and the disease continuum theory. While it has been most commonly applied to research on breast, lung, and colorectal cancers, MPE can investigate etiologic heterogeneity in non-neoplastic diseases such as cardiovascular diseases, obesity, diabetes mellitus, drug toxicity, and immunity-related and infectious diseases. This science can enhance causal inference by linking putative etiologic factors to specific molecular biomarkers as outcomes. Technological advances increasingly enable analyses of various -omics, including genomics, epigenomics, transcriptomics, proteomics, metabolomics, metagenomics, microbiome, immunomics, interactomics, etc. Challenges in MPE include sample size limitations (depending on availability of biospecimens or biomedical / radiological imaging), need for rigorous validation of molecular assays and study findings, and paucities of interdisciplinary experts, education programs, international forums, and standardized guidelines. To address these challenges, there are ongoing efforts such as multidisciplinary consortium pooling projects, the International Molecular Pathological Epidemiology (MPE) Meeting Series, and the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)-MPE guideline project. Efforts should be made to build biorepository and biobank networks, and worldwide population-based MPE databases. These activities match with the purposes of the Big Data to Knowledge (BD2K), Genetic Associations and Mechanisms in Oncology (GAME-ON), and Precision Medicine Initiatives of the United States National Institute of Health. Given advances in biotechnology, bioinformatics, and computational / systems biology, there are wide open opportunities in MPE to contribute to public health.
doi_str_mv 10.1097/EDE.0000000000000471
format Article
fullrecord <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4892980</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_4892980</sourcerecordid><originalsourceid>FETCH-LOGICAL-p140t-4fcb7399fb4ba2a6938f99defc2f817aa15b7f1b9a75d0e8725c2280733617523</originalsourceid><addsrcrecordid>eNpVjN1OwjAYhhujEUTvwIPewLB_o-2JiYGhJoBE8Xj51rVQM9ZlHSZcgbctRE3wPXm-nzwvQreUDCnR8i6bZENyGiHpGerTlNMkFUqeH2YiRMK14j10FeMHIVRyml6iHhtppiSRffS12lj8GiqLg8PzA82ughYvoduEKqy9gQpnjS_t1h_3PfY17g7KW7cr90dnYUNTQey8wVCXeBHq5OQ08dFCtPFPy1o4SsvWGh99qPHclt742l6jCwdVtDe_HKD3abYaPyWzl8fn8cMsaaggXSKcKSTX2hWiAAYjzZXTurTOMKeoBKBpIR0tNMi0JFZJlhrGFJGcj6hMGR-g-5_eZldsbWls3bVQ5U3rt9Du8wA-__-p_SZfh89cKM20IvwbiI5yZQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-Neoplastic Diseases in the Era of Precision Medicine</title><source>Jstor Complete Legacy</source><source>Journals@Ovid Complete</source><creator>Ogino, Shuji ; Nishihara, Reiko ; VanderWeele, Tyler J. ; Wang, Molin ; Nishi, Akihiro ; Lochhead, Paul ; Qian, Zhi Rong ; Zhang, Xuehong ; Wu, Kana ; Nan, Hongmei ; Yoshida, Kazuki ; Milner, Danny A ; Chan, Andrew T. ; Field, Alison E. ; Camargo, Carlos A ; Williams, Michelle A ; Giovannucci, Edward L.</creator><creatorcontrib>Ogino, Shuji ; Nishihara, Reiko ; VanderWeele, Tyler J. ; Wang, Molin ; Nishi, Akihiro ; Lochhead, Paul ; Qian, Zhi Rong ; Zhang, Xuehong ; Wu, Kana ; Nan, Hongmei ; Yoshida, Kazuki ; Milner, Danny A ; Chan, Andrew T. ; Field, Alison E. ; Camargo, Carlos A ; Williams, Michelle A ; Giovannucci, Edward L.</creatorcontrib><description>Molecular pathology diagnostics to subclassify diseases based on pathogenesis are increasingly common in clinical translational medicine. Molecular pathological epidemiology (MPE) is an integrative transdisciplinary science based on the unique disease principle and the disease continuum theory. While it has been most commonly applied to research on breast, lung, and colorectal cancers, MPE can investigate etiologic heterogeneity in non-neoplastic diseases such as cardiovascular diseases, obesity, diabetes mellitus, drug toxicity, and immunity-related and infectious diseases. This science can enhance causal inference by linking putative etiologic factors to specific molecular biomarkers as outcomes. Technological advances increasingly enable analyses of various -omics, including genomics, epigenomics, transcriptomics, proteomics, metabolomics, metagenomics, microbiome, immunomics, interactomics, etc. Challenges in MPE include sample size limitations (depending on availability of biospecimens or biomedical / radiological imaging), need for rigorous validation of molecular assays and study findings, and paucities of interdisciplinary experts, education programs, international forums, and standardized guidelines. To address these challenges, there are ongoing efforts such as multidisciplinary consortium pooling projects, the International Molecular Pathological Epidemiology (MPE) Meeting Series, and the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)-MPE guideline project. Efforts should be made to build biorepository and biobank networks, and worldwide population-based MPE databases. These activities match with the purposes of the Big Data to Knowledge (BD2K), Genetic Associations and Mechanisms in Oncology (GAME-ON), and Precision Medicine Initiatives of the United States National Institute of Health. Given advances in biotechnology, bioinformatics, and computational / systems biology, there are wide open opportunities in MPE to contribute to public health.</description><identifier>ISSN: 1044-3983</identifier><identifier>EISSN: 1531-5487</identifier><identifier>DOI: 10.1097/EDE.0000000000000471</identifier><identifier>PMID: 26928707</identifier><language>eng</language><ispartof>Epidemiology (Cambridge, Mass.), 2016-07, Vol.27 (4), p.602-611</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids></links><search><creatorcontrib>Ogino, Shuji</creatorcontrib><creatorcontrib>Nishihara, Reiko</creatorcontrib><creatorcontrib>VanderWeele, Tyler J.</creatorcontrib><creatorcontrib>Wang, Molin</creatorcontrib><creatorcontrib>Nishi, Akihiro</creatorcontrib><creatorcontrib>Lochhead, Paul</creatorcontrib><creatorcontrib>Qian, Zhi Rong</creatorcontrib><creatorcontrib>Zhang, Xuehong</creatorcontrib><creatorcontrib>Wu, Kana</creatorcontrib><creatorcontrib>Nan, Hongmei</creatorcontrib><creatorcontrib>Yoshida, Kazuki</creatorcontrib><creatorcontrib>Milner, Danny A</creatorcontrib><creatorcontrib>Chan, Andrew T.</creatorcontrib><creatorcontrib>Field, Alison E.</creatorcontrib><creatorcontrib>Camargo, Carlos A</creatorcontrib><creatorcontrib>Williams, Michelle A</creatorcontrib><creatorcontrib>Giovannucci, Edward L.</creatorcontrib><title>The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-Neoplastic Diseases in the Era of Precision Medicine</title><title>Epidemiology (Cambridge, Mass.)</title><description>Molecular pathology diagnostics to subclassify diseases based on pathogenesis are increasingly common in clinical translational medicine. Molecular pathological epidemiology (MPE) is an integrative transdisciplinary science based on the unique disease principle and the disease continuum theory. While it has been most commonly applied to research on breast, lung, and colorectal cancers, MPE can investigate etiologic heterogeneity in non-neoplastic diseases such as cardiovascular diseases, obesity, diabetes mellitus, drug toxicity, and immunity-related and infectious diseases. This science can enhance causal inference by linking putative etiologic factors to specific molecular biomarkers as outcomes. Technological advances increasingly enable analyses of various -omics, including genomics, epigenomics, transcriptomics, proteomics, metabolomics, metagenomics, microbiome, immunomics, interactomics, etc. Challenges in MPE include sample size limitations (depending on availability of biospecimens or biomedical / radiological imaging), need for rigorous validation of molecular assays and study findings, and paucities of interdisciplinary experts, education programs, international forums, and standardized guidelines. To address these challenges, there are ongoing efforts such as multidisciplinary consortium pooling projects, the International Molecular Pathological Epidemiology (MPE) Meeting Series, and the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)-MPE guideline project. Efforts should be made to build biorepository and biobank networks, and worldwide population-based MPE databases. These activities match with the purposes of the Big Data to Knowledge (BD2K), Genetic Associations and Mechanisms in Oncology (GAME-ON), and Precision Medicine Initiatives of the United States National Institute of Health. Given advances in biotechnology, bioinformatics, and computational / systems biology, there are wide open opportunities in MPE to contribute to public health.</description><issn>1044-3983</issn><issn>1531-5487</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNpVjN1OwjAYhhujEUTvwIPewLB_o-2JiYGhJoBE8Xj51rVQM9ZlHSZcgbctRE3wPXm-nzwvQreUDCnR8i6bZENyGiHpGerTlNMkFUqeH2YiRMK14j10FeMHIVRyml6iHhtppiSRffS12lj8GiqLg8PzA82ughYvoduEKqy9gQpnjS_t1h_3PfY17g7KW7cr90dnYUNTQey8wVCXeBHq5OQ08dFCtPFPy1o4SsvWGh99qPHclt742l6jCwdVtDe_HKD3abYaPyWzl8fn8cMsaaggXSKcKSTX2hWiAAYjzZXTurTOMKeoBKBpIR0tNMi0JFZJlhrGFJGcj6hMGR-g-5_eZldsbWls3bVQ5U3rt9Du8wA-__-p_SZfh89cKM20IvwbiI5yZQ</recordid><startdate>20160701</startdate><enddate>20160701</enddate><creator>Ogino, Shuji</creator><creator>Nishihara, Reiko</creator><creator>VanderWeele, Tyler J.</creator><creator>Wang, Molin</creator><creator>Nishi, Akihiro</creator><creator>Lochhead, Paul</creator><creator>Qian, Zhi Rong</creator><creator>Zhang, Xuehong</creator><creator>Wu, Kana</creator><creator>Nan, Hongmei</creator><creator>Yoshida, Kazuki</creator><creator>Milner, Danny A</creator><creator>Chan, Andrew T.</creator><creator>Field, Alison E.</creator><creator>Camargo, Carlos A</creator><creator>Williams, Michelle A</creator><creator>Giovannucci, Edward L.</creator><scope>5PM</scope></search><sort><creationdate>20160701</creationdate><title>The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-Neoplastic Diseases in the Era of Precision Medicine</title><author>Ogino, Shuji ; Nishihara, Reiko ; VanderWeele, Tyler J. ; Wang, Molin ; Nishi, Akihiro ; Lochhead, Paul ; Qian, Zhi Rong ; Zhang, Xuehong ; Wu, Kana ; Nan, Hongmei ; Yoshida, Kazuki ; Milner, Danny A ; Chan, Andrew T. ; Field, Alison E. ; Camargo, Carlos A ; Williams, Michelle A ; Giovannucci, Edward L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p140t-4fcb7399fb4ba2a6938f99defc2f817aa15b7f1b9a75d0e8725c2280733617523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ogino, Shuji</creatorcontrib><creatorcontrib>Nishihara, Reiko</creatorcontrib><creatorcontrib>VanderWeele, Tyler J.</creatorcontrib><creatorcontrib>Wang, Molin</creatorcontrib><creatorcontrib>Nishi, Akihiro</creatorcontrib><creatorcontrib>Lochhead, Paul</creatorcontrib><creatorcontrib>Qian, Zhi Rong</creatorcontrib><creatorcontrib>Zhang, Xuehong</creatorcontrib><creatorcontrib>Wu, Kana</creatorcontrib><creatorcontrib>Nan, Hongmei</creatorcontrib><creatorcontrib>Yoshida, Kazuki</creatorcontrib><creatorcontrib>Milner, Danny A</creatorcontrib><creatorcontrib>Chan, Andrew T.</creatorcontrib><creatorcontrib>Field, Alison E.</creatorcontrib><creatorcontrib>Camargo, Carlos A</creatorcontrib><creatorcontrib>Williams, Michelle A</creatorcontrib><creatorcontrib>Giovannucci, Edward L.</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Epidemiology (Cambridge, Mass.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ogino, Shuji</au><au>Nishihara, Reiko</au><au>VanderWeele, Tyler J.</au><au>Wang, Molin</au><au>Nishi, Akihiro</au><au>Lochhead, Paul</au><au>Qian, Zhi Rong</au><au>Zhang, Xuehong</au><au>Wu, Kana</au><au>Nan, Hongmei</au><au>Yoshida, Kazuki</au><au>Milner, Danny A</au><au>Chan, Andrew T.</au><au>Field, Alison E.</au><au>Camargo, Carlos A</au><au>Williams, Michelle A</au><au>Giovannucci, Edward L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-Neoplastic Diseases in the Era of Precision Medicine</atitle><jtitle>Epidemiology (Cambridge, Mass.)</jtitle><date>2016-07-01</date><risdate>2016</risdate><volume>27</volume><issue>4</issue><spage>602</spage><epage>611</epage><pages>602-611</pages><issn>1044-3983</issn><eissn>1531-5487</eissn><abstract>Molecular pathology diagnostics to subclassify diseases based on pathogenesis are increasingly common in clinical translational medicine. Molecular pathological epidemiology (MPE) is an integrative transdisciplinary science based on the unique disease principle and the disease continuum theory. While it has been most commonly applied to research on breast, lung, and colorectal cancers, MPE can investigate etiologic heterogeneity in non-neoplastic diseases such as cardiovascular diseases, obesity, diabetes mellitus, drug toxicity, and immunity-related and infectious diseases. This science can enhance causal inference by linking putative etiologic factors to specific molecular biomarkers as outcomes. Technological advances increasingly enable analyses of various -omics, including genomics, epigenomics, transcriptomics, proteomics, metabolomics, metagenomics, microbiome, immunomics, interactomics, etc. Challenges in MPE include sample size limitations (depending on availability of biospecimens or biomedical / radiological imaging), need for rigorous validation of molecular assays and study findings, and paucities of interdisciplinary experts, education programs, international forums, and standardized guidelines. To address these challenges, there are ongoing efforts such as multidisciplinary consortium pooling projects, the International Molecular Pathological Epidemiology (MPE) Meeting Series, and the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)-MPE guideline project. Efforts should be made to build biorepository and biobank networks, and worldwide population-based MPE databases. These activities match with the purposes of the Big Data to Knowledge (BD2K), Genetic Associations and Mechanisms in Oncology (GAME-ON), and Precision Medicine Initiatives of the United States National Institute of Health. Given advances in biotechnology, bioinformatics, and computational / systems biology, there are wide open opportunities in MPE to contribute to public health.</abstract><pmid>26928707</pmid><doi>10.1097/EDE.0000000000000471</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1044-3983
ispartof Epidemiology (Cambridge, Mass.), 2016-07, Vol.27 (4), p.602-611
issn 1044-3983
1531-5487
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4892980
source Jstor Complete Legacy; Journals@Ovid Complete
title The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-Neoplastic Diseases in the Era of Precision Medicine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T14%3A35%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Role%20of%20Molecular%20Pathological%20Epidemiology%20in%20the%20Study%20of%20Neoplastic%20and%20Non-Neoplastic%20Diseases%20in%20the%20Era%20of%20Precision%20Medicine&rft.jtitle=Epidemiology%20(Cambridge,%20Mass.)&rft.au=Ogino,%20Shuji&rft.date=2016-07-01&rft.volume=27&rft.issue=4&rft.spage=602&rft.epage=611&rft.pages=602-611&rft.issn=1044-3983&rft.eissn=1531-5487&rft_id=info:doi/10.1097/EDE.0000000000000471&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_4892980%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/26928707&rfr_iscdi=true